Moreover, Sollazzo et al. observed a similar level of plasmatic CALR between JAK2- and CALR-mutated MPN patients [36], suggesting that the secretion of mutant CALR proteins is not massive. This evidence concerns the gene CALR and myeloproliferative neoplasm.